Empiric Slow Pathway Ablation vs. no Ablation in Patients With Non-Inducible Supraventricular Tachycardia
Ramanathan Velayutham1, Anish Bhargav1, Raja J Selvaraj1
1Department of Cardiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Introduction:
Paroxysmal supraventricular tachycardia (PSVT) is a common cause of palpitations, with atrioventricular nodal re-entrant tachycardia (AVNRT) accounting for up to 60% of cases. In approximately 5% of patients, tachycardia is non-inducible during electrophysiology (EP) study, despite the presence of dual AV nodal physiology (DAVNP). The optimal management of patients with DAVNP and non-inducible tachycardia, whether to perform empiric ablation or not to ablate remains uncertain.
Objective:
To compare recurrence rates, mechanism of recurrence and timing of recurrence between patients who underwent empiric slow pathway ablation versus those who did not.
Methods:
We retrospectively reviewed EP studies from 2010 to 2024. Patients with documented adenosine responsive PSVT, DAVNP but non-inducible tachycardia were included; those with accessory pathways or structural heart disease were excluded. Among 1, 890 patients, 76 met inclusion criteria: Group I (n = 20) underwent empiric ablation, and Group II (n = 56) did not.
Results:
The mean age was 50.2 ± 16 years, and 62% were female. During a mean follow-up of 3.8 years, recurrence rates were similar (15% vs. 26.7%, p = 0.28)., but no patients in empiric ablation group had AVNRT whereas 53% of non-ablation patients had AVNRT. All the early recurrences were due to AVNRT while the late recurrences were predominantly due to non AVNRT arrhythmias. Time to recurrence was longer in the ablation group (54 vs. 9.8 months). There were no AV blocks after empiric ablation CONCLUSION: In patients with DAVNP and non-inducible tachycardia, overall recurrence rates are similar regardless of empiric ablation, however it is efficacious is preventing early arrhythmia recurrence and true AVNRT recurrences.
More Related Videos
10:17Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Related Concept Videos
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias VI: Management of Dysrhythmias
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
